• Mr. Speaker, the nation's highest honor for clinical research, the Lasker -DeBakey Award , was recently awarded to Jim Allison, Ph.D., chair of Immunology at The University of Texas MD AndersonCancer Center.
  • Dr. Allison has invented a completely new way to strike cancer. He has found a way to unlock the shackles of an immune system, freeing T cells to fight tumor cells. This discovery opens up brand new and very effective ways to treat cancer.
  • A drug developed from this research was the first to increase survival of patients with late-stage melanoma and produced previously unheard of survival rates of up to 10 years.
  • The drug, marketed as Yervoy, was approved by the FDA in 2001 and has been used to treat 59,000 people.
  • In addition, during his time leading the immunology department at MD Anderson , Dr. Allison has established a cancer immunotherapy platform. This platform, a combination of expertise and infrastructure, brings together scientists and clinicians to better understand and advance cancer immunotherapy.
  • This prestigious award honoring major achievements in basic science, clinical research, and public service around the world is rightly bestowed on Dr. Allison, as he has paved the way to extend the survival of current cancer patients and ultimately cure some types of cancer.
  • Texas is proud to be home to such innovative and groundbreaking work happening at MD Anderson .
  • And that's just the way it is.